- Home
- CSTL vs DDL Comparison
CSTL vs DDL Comparison
Compare CSTL & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- DDL
- Stock Information
- Founded
- CSTL 2007
- DDL 2014
- Country
- CSTL United States
- DDL China
- Employees
- CSTL 784
- DDL N/A
- Industry
- CSTL Medical Specialities
- DDL Catalog/Specialty Distribution
- Sector
- CSTL Health Care
- DDL Consumer Discretionary
- Exchange
- CSTL Nasdaq
- DDL Nasdaq
- Market Cap
- CSTL 456.2M
- DDL 457.4M
- IPO Year
- CSTL 2019
- DDL 2021
- Fundamental
- Price
- CSTL $15.95
- DDL $2.06
- Analyst Decision
- CSTL Strong Buy
- DDL
- Analyst Count
- CSTL 6
- DDL 0
- Target Price
- CSTL $37.67
- DDL N/A
- AVG Volume (30 Days)
- CSTL 527.3K
- DDL 928.6K
- Earning Date
- CSTL 05-05-2025
- DDL 05-16-2025
- Dividend Yield
- CSTL N/A
- DDL N/A
- EPS Growth
- CSTL N/A
- DDL N/A
- EPS
- CSTL N/A
- DDL 0.18
- Revenue
- CSTL $347,083,000.00
- DDL $3,241,404,122.00
- Revenue This Year
- CSTL N/A
- DDL $10.17
- Revenue Next Year
- CSTL $1.80
- DDL $16.08
- P/E Ratio
- CSTL N/A
- DDL $11.35
- Revenue Growth
- CSTL 38.43
- DDL 17.62
- 52 Week Low
- CSTL $15.45
- DDL $1.62
- 52 Week High
- CSTL $35.84
- DDL $4.79
- Technical
- Relative Strength Index (RSI)
- CSTL 33.63
- DDL 37.66
- Support Level
- CSTL $15.45
- DDL $1.95
- Resistance Level
- CSTL $16.43
- DDL $2.18
- Average True Range (ATR)
- CSTL 0.59
- DDL 0.12
- MACD
- CSTL 0.04
- DDL -0.02
- Stochastic Oscillator
- CSTL 15.93
- DDL 17.95
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.